Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,079,979 | 805,593 | 925,250 | 634,368 | 519,757 |
| Marketable Securities | 46,948 | 119,146 | 178,138 | 247,757 | 121,629 |
| Receivables | 180,340 | 189,115 | 166,133 | 73,750 | 75,688 |
| Inventories | 25,550 | 32,331 | 26,206 | 25,051 | 16,354 |
| Other current assets | 161,357 | 195,651 | 165,959 | 0 | 0 |
| TOTAL | $1,547,196 | $1,381,540 | $1,496,576 | $1,011,434 | $759,730 |
| Non-Current Assets | |||||
| PPE Net | 541,963 | 537,432 | 514,182 | 485,275 | 443,656 |
| Investments And Advances | 52,149 | 179,587 | 187,782 | 314,364 | 393,904 |
| Intangibles | 489,376 | 515,720 | 512,001 | 500,735 | 524,958 |
| Other Non-Current Assets | 286,641 | 207,470 | 154,846 | 221,746 | 187,858 |
| TOTAL | $1,370,129 | $1,440,209 | $1,368,811 | $1,522,120 | $1,550,376 |
| Total Assets | $2,917,325 | $2,821,749 | $2,865,387 | $2,533,554 | $2,310,106 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,617 | 15,212 | 21,922 | 14,373 | 17,544 |
| Accrued Expenses | 219,974 | 268,144 | 243,128 | 207,034 | 169,055 |
| Other current liabilities | 15,436 | 19,991 | 17,468 | N/A | N/A |
| TOTAL | $267,109 | $306,853 | $285,198 | $245,773 | $213,083 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 23,150 | 24,180 |
| Other Non-Current Liabilities | 211,555 | 201,512 | 209,127 | 106,889 | 82,380 |
| TOTAL | $211,811 | $201,866 | $209,686 | $143,939 | $118,288 |
| Total Liabilities | $478,920 | $508,719 | $494,884 | $389,712 | $331,371 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,349 | 100,201 | 103,263 | 102,289 | 101,484 |
| Common Shares | 99 | 99 | 102 | 101 | 101 |
| Retained earnings | 2,443,138 | 2,327,877 | 2,313,539 | 2,083,063 | 1,938,320 |
| Other shareholders' equity | -4,832 | -14,946 | -9,265 | -653 | -1,718 |
| TOTAL | $2,438,405 | $2,313,030 | $2,370,503 | $2,143,842 | $1,978,735 |
| Total Liabilities And Equity | $2,917,325 | $2,821,749 | $2,865,387 | $2,533,554 | $2,310,106 |